For hydroxamic acids with high HDAC6-inhibiting activity, we also conducted docking analyses against the crystal structure of HDAC6 (PDB: 5EDU), where the features of the interaction of compounds with the sixth isoform of human HDAC, most commonly associated with Alzheimer’s disease, were revealed. This evidence concerns the gene HDAC9 and early-onset autosomal dominant Alzheimer disease.